Parisi Gray Wealth Management’s Bio-Rad Laboratories Class A BIO Stock Holding History

Parisi Gray Wealth Management’s Portfolio BIO Stock Details BIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-203	Closed	-$131K	–	180
2021 Q2	$131K	Buy	+203	New	+$124K	0.05%	163
2019 Q2	–	Sell	-177	Closed	-$54K	–	151
2019 Q1	$54K	Hold	177	–	–	0.03%	217
2018 Q4	$41K	Hold	177	–	–	0.03%	228
2018 Q3	$55K	Hold	177	–	–	0.03%	209
2018 Q2	$53K	Hold	177	–	–	0.04%	221
2018 Q1	$44K	Buy	177 +36	+26%	+$9.17K	0.03%	234
2017 Q4	$34K	Buy	+141	New	+$34.2K	0.03%	271

Other funds holding BIO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Parisi Gray Wealth Management's BIO Position: Q3 2021 in Review

Parisi Gray Wealth Management sold out of Bio-Rad Laboratories Class A (BIO) in Q3 2021, closing a stake of 203 shares — an estimated $131K sold.

Parisi Gray Wealth Management first reported a position in BIO in Q4 2017 and held it in 7 quarters. The position peaked at $131K in Q2 2021. 508 funds tracked by Wall St. Rank hold BIO as of Q3 2021.

Parisi Gray Wealth Management reported no remaining Bio-Rad Laboratories Class A position as of Q3 2021 after selling out during the quarter.
Parisi Gray Wealth Management sold 203 Bio-Rad Laboratories Class A shares in Q3 2021, an estimated $131K.
Parisi Gray Wealth Management first reported a position in Bio-Rad Laboratories Class A in Q4 2017 and held it in 7 quarters.
Parisi Gray Wealth Management's Bio-Rad Laboratories Class A position peaked at $131K in Q2 2021.
508 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q3 2021.

Based on Parisi Gray Wealth Management's 13F filing for Q3 2021, filed 16 Nov 2021.